DIN 02247937 — APO-HYDROXYUREA 500 MG
APO-HYDROXYUREA is a capsule of Hydroxyurea marketed by APOTEX INC. The full Hydroxyurea monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02247937
- Brand name
- APO-HYDROXYUREA
- Active ingredient
- Hydroxyurea
- Strength
- 500 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent (ribonucleotide reductase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hydroxyurea products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00465283 | HYDREA | 500 MG | CAPSULE | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |
| 02242920 | MYLAN-HYDROXYUREA | 500 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02530260 | RIVA-HYDROXYUREA | 500 MG | CAPSULE | LABORATOIRE RIVA INC. | MARKETED |